ENDRA Life Sciences Inc. (NDRA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 250K 500K 750K Q3 '24: 632.6K Q4 '24: 571K Q1 '25: 401.4K Q2 '25: 307.3K Q3 '25: 269.4K Q4 '25: 189.5K Q1 '26: 124.8K Q2 '26: 61.7K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit TTM

0 70K 140K 210K Q1 '18: 185K Q2 '18: 178.7K Q3 '18: 9.9K Q4 '18: 6.2K Q1 '19: 0 Q2 '19: 0 Q3 '19: 0 Q4 '19: 0 Q1 '18 Q2 '18 Q3 '18 Q4 '18 Q1 '19 Q2 '19 Q3 '19 Q4 '19

Operating Income TTM

-12M -8M -4M 0 4M 8M 12M Q3 '24: -8M Q4 '24: -10.8M Q1 '25: -9.5M Q2 '25: -8.6M Q3 '25: -8.4M Q4 '25: -5.8M Q1 '26: -6.5M Q2 '26: -6.6M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income TTM

-12M -8M -4M 0 4M 8M 12M Q3 '24: -8.8M Q4 '24: -11.5M Q1 '25: -9.8M Q2 '25: -8.8M Q3 '25: -8M Q4 '25: -7M Q1 '26: -7.3M Q2 '26: -5.9M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue TTM

0 Q4 '18: 0 Q1 '19: 0 Q2 '19: 0 Q3 '19: 0 Q4 '19: 0 Q4 '18 Q1 '19 Q2 '19 Q3 '19 Q4 '19

Operating Cash Flow TTM

-9M -6M -3M 0 3M 6M 9M Q3 '24: -8.1M Q4 '24: -7.4M Q1 '25: -6.5M Q2 '25: -5.6M Q3 '25: -5.1M Q4 '25: -5.2M Q1 '26: -5M Q2 '26: -4.8M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow TTM

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q1 '24: -9.2M Q2 '24: -9M Q3 '24: -8.1M Q4 '24: -7.4M Q1 '25: -6.6M Q2 '25: -5.6M Q3 '25: -5.1M Q4 '25: -5.2M Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 900K 1.8M 2.7M Q3 '24: 246.8K Q1 '25: 557.6K Q2 '25: 717.1K Q3 '25: 761.2K Q1 '26: 1.2M Q2 '26: 2.5M Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-10.50 -7.00 -3.50 0.00 3.50 7.00 10.50 Q3 '20: -1.84 Q4 '20: -0.86 Q1 '21: -0.63 Q2 '21: -0.51 Q3 '21: -0.42 Q4 '25: -8.92 Q1 '26: -8.15 Q2 '26: -6.38 Q3 '20 Q4 '20 Q1 '21 Q2 '21 Q3 '21 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.